XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
STATEMENT OF STOCKHOLDERS' DEFICIT - USD ($)
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Common Stock
Paid in Capital
Cumulative Effect, Period of Adoption, Adjustment
Paid in Capital
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Total
Beginning balance (ASU 2020-06) at Dec. 31, 2021       $ (1,013,414)   $ 634,059   $ (379,355)  
Beginning balance at Dec. 31, 2021 $ 355,000   $ 876   $ 20,804,333   $ (21,882,712)   $ (722,503)
Beginning balance (in shares) at Dec. 31, 2021 500,000   87,725,842            
Increase (Decrease) in Stockholders' Equity                  
Shares issued for consulting services     $ 106   356,794       356,900
Shares issued for consulting services (in shares)     10,600,000            
Warrants issued in conjunction with convertible promissory notes         142,996       142,996
Warrants reset in conjunction with convertible promissory notes         63,381   (63,381)    
Cashless warrant exercises     $ 51   (51)        
Cashless warrant exercises (in shares)     5,129,725            
Issuance of common stock for cash     $ 15   42,751       42,766
Issuance of common stock for cash (in shares)     1,500,000            
Stock-based compensation         4,703       4,703
Net loss             (1,144,536)   (1,144,536)
Ending balance at Mar. 31, 2022 $ 355,000   $ 1,048   20,401,493   (22,456,570)   (1,699,029)
Ending balance (in shares) at Mar. 31, 2022 500,000   104,955,567            
Beginning balance (ASU 2020-06) at Dec. 31, 2021       $ (1,013,414)   $ 634,059   $ (379,355)  
Beginning balance at Dec. 31, 2021 $ 355,000   $ 876   20,804,333   (21,882,712)   (722,503)
Beginning balance (in shares) at Dec. 31, 2021 500,000   87,725,842            
Increase (Decrease) in Stockholders' Equity                  
Net loss                 (2,638,413)
Ending balance at Sep. 30, 2022 $ 365,000   $ 1,577   21,867,892   (23,970,227)   (1,735,758)
Ending balance (in shares) at Sep. 30, 2022 1,000,000   157,950,530            
Beginning balance at Mar. 31, 2022 $ 355,000   $ 1,048   20,401,493   (22,456,570)   (1,699,029)
Beginning balance (in shares) at Mar. 31, 2022 500,000   104,955,567            
Increase (Decrease) in Stockholders' Equity                  
Shares issued for consulting services     $ 30   44,970       45,000
Shares issued for consulting services (in shares)     3,000,000            
Shares issued in conjunction with forbearance of convertible promissory notes     $ 40   142,760       142,800
Shares issued in conjunction with forbearance of convertible promissory notes (in shares)     4,000,000            
Convertible promissory notes payable settlement     $ 267   668,103       668,370
Convertible promissory notes payable settlement (in shares)     26,734,801            
Warrants issued in conjunction with debt extinguishment         65,000       65,000
Cashless warrant exercises     $ 35   (35)        
Cashless warrant exercises (in shares)     3,550,162            
Net loss             (535,931)   (535,931)
Ending balance at Jun. 30, 2022 $ 355,000   $ 1,420   21,322,291   (22,992,501)   (1,313,790)
Ending balance (in shares) at Jun. 30, 2022 500,000   142,240,530            
Increase (Decrease) in Stockholders' Equity                  
Shares issued for consulting services     $ 68   67,932       68,000
Shares issued for consulting services (in shares)     6,800,000            
Warrants issued in conjunction with convertible promissory notes         302,978       302,978
Warrants reset in conjunction with convertible promissory notes         19,780   (19,780)    
Cashless warrant exercises     $ 27   (27)        
Cashless warrant exercises (in shares)     2,710,000            
Conversion of convertible promissory note     $ 62   154,938       155,000
Conversion of convertible promissory note (In shares)     6,200,000            
Stock-based compensation $ 10,000               10,000
Stock-based compensation (in shares) 500,000                
Net loss             (957,946)   (957,946)
Ending balance at Sep. 30, 2022 $ 365,000   $ 1,577   21,867,892   (23,970,227)   (1,735,758)
Ending balance (in shares) at Sep. 30, 2022 1,000,000   157,950,530            
Beginning balance at Dec. 31, 2022 $ 365,000   $ 1,896   22,237,300   (24,825,041)   (2,220,845)
Beginning balance (in shares) at Dec. 31, 2022 1,000,000   189,784,529            
Increase (Decrease) in Stockholders' Equity                  
Shares issued for consulting services     $ 350   314,650       315,000
Shares issued for consulting services (in shares)     35,000,000            
Share issued as CEO compensation   $ 400,000             400,000
Share issued as CEO compensation (in shares)   1              
Shares issued in conjunction with settlement reset     $ 461   697,539       698,000
Shares issued in conjunction with settlement reset (in shares)     46,102,156            
Cashless warrant exercises     $ 180   (180)        
Cashless warrant exercises (in shares)     18,000,000            
Trigger warrants issued         160,000       160,000
Conversion of convertible promissory note     $ 50   49,950       50,000
Conversion of convertible promissory note (In shares)     5,000,000            
Settlement of stock - based compensation liabilities     $ 30   20,970       21,000
Settlement of stock - based compensation liabilities (in shares)     3,000,000            
Net loss             (456,063)   (456,063)
Ending balance at Mar. 31, 2023 $ 365,000 $ 400,000 $ 2,967   23,480,229   (25,281,104)   (1,032,908)
Ending balance (in shares) at Mar. 31, 2023 1,000,000 1 296,886,685            
Beginning balance at Dec. 31, 2022 $ 365,000   $ 1,896   22,237,300   (24,825,041)   (2,220,845)
Beginning balance (in shares) at Dec. 31, 2022 1,000,000   189,784,529            
Increase (Decrease) in Stockholders' Equity                  
Warrant reset                 3,461
Net loss                 (2,292,589)
Ending balance at Sep. 30, 2023 $ 365,000 $ 400,000 $ 4,713   23,835,454   (27,121,091)   (2,515,924)
Ending balance (in shares) at Sep. 30, 2023 1,000,000 1 471,495,856            
Beginning balance at Mar. 31, 2023 $ 365,000 $ 400,000 $ 2,967   23,480,229   (25,281,104)   (1,032,908)
Beginning balance (in shares) at Mar. 31, 2023 1,000,000 1 296,886,685            
Increase (Decrease) in Stockholders' Equity                  
Conversion of convertible promissory note     $ 1,315   209,376       210,691
Conversion of convertible promissory note (In shares)     131,532,211            
Conversion true-up     $ 41   (41)        
Conversion true-up (in shares)     4,075,000            
Warrant reset         3,461   (3,461)    
Net loss             (1,459,806)   (1,459,806)
Ending balance at Jun. 30, 2023 $ 365,000 $ 400,000 $ 4,323   23,693,025   (26,744,371)   (2,282,023)
Ending balance (in shares) at Jun. 30, 2023 1,000,000 1 432,493,896            
Increase (Decrease) in Stockholders' Equity                  
Conversion of convertible promissory note     $ 390   38,953       39,343
Conversion of convertible promissory note (In shares)     39,001,960            
Valuation of trigger warrants         103,476       103,476
Net loss             (376,720)   (376,720)
Ending balance at Sep. 30, 2023 $ 365,000 $ 400,000 $ 4,713   $ 23,835,454   $ (27,121,091)   $ (2,515,924)
Ending balance (in shares) at Sep. 30, 2023 1,000,000 1 471,495,856